05/26/2022

Challenges in the determination of two analytes with different physicochemical properties, Tapinarof and its main metabolite, Tapinarof Sulfate, at the low picogram level

The challenge of developing a new bioanalytical method considerably increases when two or more metabolites need to be simultaneously analysed. Their extraction and chromatography optimization can be further complicated if their physicochemical properties vary significantly. Method development may be even more difficult when low limits of quantitation are required, for instance, when evaluating the systemic adsorption of topical drugs.

In the work we present to the 8th EBF Young Scientist Symposium, which was awarded with the "Second Best Poster Award", we show the challenges encountered and the potential solutions of developing a fairly sensitive method, while trying to simultaneously extract and analyse two analytes, Tapinarof and, its main phase-II metabolite, Tapinarof Sulfate, whose physicochemical properties are quite different.

You may find below the poster for your ready reference:

MORE NEWS

09/12/2024 15:38

Overcoming Matrix Effects in the Analysis of Lipophilic Compounds

At the 10th EBF Young Scientist Symposium, we highlighted the complexities of analysing Fucoxanthin derivatives and demonstrated how innovative approaches, such as 2D Chromatography, can overcome these obstacles.

READ MORE
09/12/2024 15:12

Overcoming Analytical Challenges in Liraglutide & Semaglutide Analysis

The work presented at the 10th EBF Young Scientist Symposium highlights the analytical challenges of developing UPLC/MS/MS methodologies for the extraction and quantification of Liraglutide and Semaglutide in plasma, while also outlining the strategies employed to solve them.

READ MORE
26/11/2024 15:03

Anapharm Bioanalytics Recognized as an Innovative SME

We are thrilled to announce that Anapharm Bioanalytics has recently been officially recognized as an Innovative SME (PYME Innovadora) by the Spanish Ministry of Science and Innovation.

READ MORE